India to Morocco: Salmeterol Export Trade Route

The India to Morocco Salmeterol corridor is one of India's established pharmaceutical export routes, with 112 shipments documented worth a combined $5.8M USD. The route is dominated by CIPLA LIMITED , which alone accounts for roughly 55% of all export value, reflecting the consolidated nature of India's salmeterol manufacturing sector.

Across 5 active suppliers, the average shipment value stands at $52.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with salmeterol's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 16.3%, placing it at rank #10 among India's top salmeterol export destinations globally.

On the import side, key buyers of Indian salmeterol in Morocco include CIPLA MAROC , CIPLA MAROC, CIPLA MAROC.. and 4 others. CIPLA MAROC is the single largest importer with 55 shipments valued at $3.2M USD.

India's salmeterol exports to Morocco are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 55 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Morocco benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED , CIPLA LIMITED, HETERO LABS LIMITED — together account for 97% of total trade value on this route. The average shipment value of $52.1K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as saflu 250 inhaler (cfc free) (salmeterolxinafoate 25mcg+fluticasone propionate250mcg )(ps:1x120md) and saflu 250 inhaler (cfc free) (salmeterol xinafoate 25mcg+fluticasonepropionate 250mcg) (1 x 120 md), suggesting that buyers in Morocco tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, CIPLA MAROC is the largest importer with 55 shipments worth $3.2M USD — representing 55% of all salmeterol imports from India on this route. A total of 7 buyers are active on this corridor.